NASDAQ:RXRX

Recursion Pharmaceuticals Stock Forecast

etoro logo Buy RXRX
*Your capital is at risk
$2.95
-0.0750 (-2.48%)
At Close: Jul 17, 2026
AI Analysis AI Analysis of RXRX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RXRX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Recursion Pharmaceuticals, Inc. stock upgraded to Hold/Accumulate
(Updated on Jul 17, 2026)

Hold candidate since Jul 17, 2026

The Recursion Pharmaceuticals, Inc. stock price fell by -2.48% on the last day (Friday, 17th Jul 2026) from $3.02 to $2.95. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.07% from a day low at $2.93 to a day high of $3.02. The price has fallen in 7 of the last 10 days and is down by -22.5% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -15 million shares and in total, 19 million shares were bought and sold for approximately $56.69 million.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.90 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 2.00% during the next 3 months and, with a 90% probability hold a price between $2.96 and $4.05 at the end of this 3-month period.

RXRX Signals & Forecast

There are few to no technical positive signals at the moment. The Recursion Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.32 and $3.42. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, July 06, 2026, and so far it has fallen -25.63%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Recursion Pharmaceuticals, Inc. stock

Recursion Pharmaceuticals, Inc. finds support from accumulated volume at $2.93 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0900 between high and low, or 3.07%. For the last week, the stock has had daily average volatility of 6.27%.

Our recommended stop-loss: $2.76 (-6.34%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 9 days ago.)

Trading Expectations (RXRX) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Recursion Pharmaceuticals, Inc. to open at $2.97, and during the day (based on 14 day Average True Range), to move between $2.82 and $3.07, which gives a possible trading interval of +/-$0.244 (+/-8.65%) up or down from last closing price. If Recursion Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 8.65% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.93 (0.51%) than the resistance at $3.15 (6.96%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Recursion Pharmaceuticals, Inc. stock A Buy?

Recursion Pharmaceuticals, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.659 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $2.97 ( 0.679%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RXRX Performance

Trading levels for RXRX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.06 3.74%
R2 3.02 2.57%
R1 3.00 1.85%
Price 2.95
S1 2.93 -0.488%
S2 2.91 -1.21%
S3 2.88 -2.38%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.67 24.62%
R2 3.52 19.52%
R1 3.15 6.96%
Price 2.95
S1 2.93 -0.509%
S2 2.89 -1.87%
S3 2.85 -3.23%

FAQ

What is the symbol for Recursion Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Recursion Pharmaceuticals, Inc. is RXRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Recursion Pharmaceuticals, Inc. Stock?
Recursion Pharmaceuticals, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Recursion Pharmaceuticals, Inc. Stock?
Recursion Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Recursion Pharmaceuticals, Inc. Stock.

What's the current price of Recursion Pharmaceuticals, Inc. Stock?
As of the end of day on the Jul 17, 2026, the price of an Recursion Pharmaceuticals, Inc. (RXRX) share was $2.95.

What is the 52-week high and low for Recursion Pharmaceuticals, Inc. Stock?
The 52-week high for Recursion Pharmaceuticals, Inc. Stock is $7.18 and the 52-week low is $2.77.

What is the market capitalization of Recursion Pharmaceuticals, Inc. Stock?
As of the Jul 17, 2026, the market capitalization of Recursion Pharmaceuticals, Inc. is 1.317B.

When is the next earnings date for Recursion Pharmaceuticals, Inc.?
The upcoming earnings date for Recursion Pharmaceuticals, Inc. is Aug 04, 2026.
Click to get the best stock tips daily for free!
ABOUT RECURSION PHARMACEUTICALS, INC.
Recursion Pharmaceuticals
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 to treat familial...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
0.578% Jul 13
SRPT
$17.02
1.18% Jun 29
JLL
$299.78
10.30% Jun 24
NMRK
$15.02
3.86% Jun 24
CAG
$13.43
6.29% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE